I. Harting

发表

Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging

V. Tronnier, M. Hartmann, S. Heiland, 2003, Neuroscience Letters.

Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.

S. Heiland, I. Harting, M. J. van den Bent, 2019, The Lancet. Oncology.

Noninvasive Source Localization of Interictal EEG Spikes: Effects of Signal-to-Noise Ratio and Averaging

M. Scherg, A. Schulze-Bonhage, I. Harting, 2006, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

Subdural hematoma in glutaric aciduria type 1: High excreters are prone to incidental SDH despite newborn screening

I. Harting, A. Mohr, S. Kölker, 2021, Journal of inherited metabolic disease.

Response to trametinib treatment in progressive pediatric low-grade glioma patients

David T. W. Jones, I. Harting, S. Pfister, 2020, Journal of Neuro-Oncology.

Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy

I. Harting, F. Muntoni, K. Zerres, 2005, Nature Genetics.

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.

I. Harting, L. Hazrati, D. Eisenstat, 2020, JCO precision oncology.

Neurometabolic disorders: Five new things.

I. Harting, R. Wevers, M. Willemsen, 2016, Neurology. Clinical practice.

Lack of creatine in muscle and brain in an adult with GAMT deficiency

I. Harting, P. Bachert, E. Mayatepek, 2003, Annals of neurology.

4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System

A. Vanderver, F. Barkhof, I. Harting, 2017, Neuropediatrics.

[Focal cortical dysplasias: neuroradiological findings and differential diagnosis].

I. Harting, K. Kirchhof, A. Seitz, 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency

I. Harting, O. Bodamer, J. Zschocke, 2005, Neurology.

Use of guidelines improves the neurological outcome in glutaric aciduria type I

I. Harting, J. Zschocke, S. Kölker, 2010, Annals of neurology.

Band‐like intracranial calcification with simplified gyration and polymicrogyria: A distinct “pseudo‐TORCH” phenotype

I. Harting, Y. Crow, D. Pilz, 2008, American journal of medical genetics. Part A.

Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

K., Stevens, A. Vanderver, 2020, The Journal of clinical endocrinology and metabolism.

Ataxia, Delayed Dentition and Hypomyelination: A Novel Leukoencephalopathy

I. Harting, E. Boltshauser, D. Rating, 2007, Neuropediatrics.

[Tumor simulating lesions on cranial MR imaging].

M. Hartmann, I. Harting, K. Sartor, 2004, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Characterization of necrotic meningioma using diffusion MRI, perfusion MRI, and MR spectroscopy: case report and review of the literature

M. Hartmann, I. Harting, C. Sommer, 2004, Neuroradiology.

Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity

I. Harting, O. Bodamer, S. Kölker, 2017, Orphanet Journal of Rare Diseases.

Quantification of transcript-to-template ratios as a measure of gene expression using RT-PCR.

I. Harting, R. Wiesner, 1997, BioTechniques.

Abnormal myelination in Angelman syndrome.

I. Harting, K. Sartor, B. Janssen, 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

CCDC82 frameshift mutation associated with intellectual disability, spastic paraparesis, and dysmorphic features

I. Harting, A. Gutschalk, T. Haack, 2022, Clinical genetics.

Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease.

I. Harting, A. Agustí, P. Tomás, 1998, American journal of respiratory and critical care medicine.

Aspartylglucosaminuria: unusual neonatal presentation in Qatari twins with a novel aspartylglucosaminidase gene mutation and 3 new cases in a Turkish family.

I. Harting, C. Fischer, U. Moog, 2014, Journal of child neurology.

NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

I. Harting, M. Weller, M. Taphoorn, 2017 .

Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts

Robert W. Taylor, T. Wieland, I. Harting, 2016, Journal of Inherited Metabolic Disease.

Patterns, evolution, and severity of striatal injury in insidious‐ vs acute‐onset glutaric aciduria type 1

I. Harting, S. Kölker, S. Garbade, 2019, Journal of inherited metabolic disease.

Patterns, evolution, and severity of striatal injury in insidious- versus acute-onset glutaric aciduria type 1

I. Harting, S. Kölker, S. Garbade, 2018, Journal of Inherited Metabolic Disease.

Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies

I. Harting, M. Parker, A. van Haeringen, 2021, European Journal of Human Genetics.

SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)

Robert W. Taylor, I. Harting, T. Meitinger, 2018, Genetics in Medicine.

Leukoencephalopathy with ataxia, hypodontia, and hypomyelination

I. Harting, E. Boltshauser, E. Martin, 2005, Neurology.

Acute haemorrhage into a microcystic meningioma leading to cerebral herniation

I. Harting, O. Sakowitz, A. Unterberg, 2005, British journal of neurosurgery.

Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features

I. Harting, T. Bast, S. Rahman, 2009, Epilepsia.

New pattern of brain MRI lesions in isolated complex I deficiency.

I. Harting, J. Smeitink, L. P. Van den Heuvel, 2003, Neuropediatrics.

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

Johannes Zschocke, Thomas Opladen, I. Harting, 2017, Journal of Inherited Metabolic Disease.

Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)

I. Harting, S. Kölker, E. Neumaier-Probst, 2004, Journal of Inherited Metabolic Disease.

Adult &agr;-mannosidosis: Clinical progression in the absence of demyelination

I. Harting, A. Gutschalk, H. Meinck, 2004, Neurology.

Lomustine and Bevacizumab in Progressive Glioblastoma

Martin Klein, Michael Platten, Martin Bendszus, 2017, The New England journal of medicine.

A vaccine targeting mutant IDH1 in newly diagnosed glioma

S. Stevanović, I. Harting, S. Justesen, 2021, Nature.

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

David T. W. Jones, C. Plass, I. Harting, 2020, BMC Cancer.

SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)

Robert W. Taylor, I. Harting, T. Meitinger, 2018, Genetics in Medicine.

Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1

J. Rosenfeld, J. Lupski, D. Horn, 2020, Genetics in Medicine.

Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy

Thomas Meitinger, Julien Gagneur, Holger Prokisch, 2015, American journal of human genetics.

Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy.

M. Carl, I. Harting, T. Meitinger, 2016, American journal of human genetics.

Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1

J. Rosenfeld, J. Lupski, D. Horn, 2020, Genetics in Medicine.

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

I. Harting, M. J. van den Bent, M. Weller, 2019, Neurology.

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

J. Pichler, I. Harting, A. von Deimling, 2014, Clinical Cancer Research.

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation

I. Harting, A. Ho, U. Martens, 2022, Bone Marrow Transplantation.

Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients

I. Harting, D. Zafeiriou, J. Friedman, 2021, Journal of inherited metabolic disease.

Interpeduncular Heterotopia in Joubert Syndrome: A Previously Undescribed MR Finding

I. Harting, M. Bendszus, A. Poretti, 2011, American Journal of Neuroradiology.

Oculodentodigital Dysplasia: A Hypomyelinating Leukodystrophy with a Characteristic MRI Pattern of Brain Stem Involvement

I. Harting, U. Moog, P. Pouwels, 2019, American Journal of Neuroradiology.

I. Harting, S. Kölker, S. Garbade, 2018, Neuropediatrics.

MRI and 1H-MRS in adenosine kinase deficiency

I. Harting, H. Blom, S. Kölker, 2016, Neuroradiology.

ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS

S. Stevanović, I. Harting, W. Wick, 2018, Neuro-Oncology.

OS6.4 NOA-16: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas

I. Harting, A. von Deimling, G. Tabatabai, 2018, Neuro-Oncology.

[Magnetic resonance spectroscopy of brain tumours].

M. Hartmann, I. Harting, G. Jost, 2005, Der Nervenarzt.

Combination of caudal myxopapillary ependymoma and dermal sinus: a single shared embryologic lesion?

I. Harting, C. Sommer, F. Ebinger, 2003, Developmental medicine and child neurology.

POLR3A variants with striatal involvement and extrapyramidal movement disorder

I. Harting, P. Pouwels, I. Krägeloh-Mann, 2020, neurogenetics.

T2-hyperintense cerebellar cortex in Marinesco–Sjögren syndrome

I. Harting, K. Sartor, H. Goebel, 2004, Neurology.

4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System.

A. Vanderver, F. Barkhof, I. Harting, 2017, Neuropediatrics.

Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2γ translational function, and literature review

I. Harting, T. Strom, V. Kalscheuer, 2020, Clinical genetics.

Looking beyond the basal ganglia: The spectrum of MRI changes in methylmalonic acidaemia

I. Harting, S. Kölker, M. Lindner, 2008, Journal of Inherited Metabolic Disease.

Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.

I. Harting, J. Zschocke, S. Kölker, 2009, Brain : a journal of neurology.

1H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites

I. Harting, P. Pouwels, M. Bendszus, 2015, Journal of Inherited Metabolic Disease.

Diffuse cortical necrosis in a neonate with incontinentia pigmenti and an encephalitis-like presentation.

I. Harting, D. Rating, F. Ebinger, 2005, AJNR. American journal of neuroradiology.

MANGANESE deficiency.

E. Zackai, G. Reifenberger, T. Dierks, 2022, Journal of the American Veterinary Medical Association.

Dental diplopia with transient abducens palsy

I. Harting, Helios Klinikum Erfurt, H. Erfurt, 2004 .

Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF

I. Harting, P. Pouwels, U. Engelke, 2004, Neurology.

Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy

M. Hartmann, S. Heiland, I. Harting, 2003, Neuroscience Letters.

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision

M. Baumgartner, I. Harting, B. Plecko, 2022, Journal of inherited metabolic disease.

Combined EEG and MEG analysis of early somatosensory evoked activity in children and adolescents with focal epilepsies

K. Hoechstetter, A. Rupp, U. Baumgärtner, 2007, Clinical Neurophysiology.

Identification of PMD subgroups using a myelination score for PMD.

A. Vanderver, I. Harting, A. Mohr, 2022, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Prevalence of fascicular hyperintensities in peripheral nerves of healthy individuals with regard to cerebral white matter lesions

S. Heiland, I. Harting, M. Bendszus, 2019, European Radiology.

Quantitative single‐voxel spectroscopy: The reciprocity principle for receive‐only head coils

Gregor Jost, Sabine Heiland, S. Heiland, 2005, Journal of magnetic resonance imaging : JMRI.

Encephalitis-Like Presentation Incontinentia Pigmenti and an Diffuse Cortical Necrosis in a Neonate with

I. Harting, F. Ebinger, A. Seitz, 2005 .

[Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].

I. Harting, K. Sartor, U. Meyding-Lamadé, 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Maternal uniparental disomy for chromosome 14.

E. Zackai, G. Reifenberger, T. Dierks, 1991, Journal of medical genetics.

Mesangiocapillary glomerulonephritis.

E. Zackai, I. Harting, B. McGuinness, 1992, Journal of the American Society of Nephrology : JASN.

Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.

I. Harting, J. Zschocke, S. Kölker, 2009, Brain : a journal of neurology.

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

I. Harting, C. Greenberg, J. Zschocke, 2017, Journal of Inherited Metabolic Disease.

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

J. Pichler, I. Harting, A. von Deimling, 2014, Clinical Cancer Research.

LGG-55. OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION

I. Harting, L. Hazrati, D. Eisenstat, 2020, Neuro-Oncology.

Five new things

I. Harting, R. Wevers, M. Willemsen, 2022 .

Micronutrient Deficiencies

T. Dierks, I. Harting, J. Hellemans, 2010 .